Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
32 hedge funds and large institutions have $23.5M invested in Global Cord Blood Corporation in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 2 closing their positions.
7% more capital invested
Capital invested by funds: $22M → $23.5M (+$1.44M)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
3% less funds holding
Funds holding: 33 → 32 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.68M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$576K |
| 3 |
BlackRock
New York
|
+$127K |
| 4 |
Millennium Management
New York
|
+$56.7K |
| 5 |
JP Morgan Chase
New York
|
+$51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$439K |
| 2 |
Man Group
London,
United Kingdom
|
-$79.1K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$50K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$45.3K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Group One Trading
Chicago,
Illinois
| $6K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $2K | -$3.96K | -1,365 | -65% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $2K | -$2.3K | -792 | -61% |
|
|
SPIA
29
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$845 | +291 | +86% |
|
|
PP
31
Paloma Partners
Greenwich,
Connecticut
| – | -$50K | -15,633 | Closed |
|
|
ECM
32
ExodusPoint Capital Management
New York
| – | -$33K | -10,283 | Closed |
|
CO Hedge Fund Activity: Q2 2020 in Review
32 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2020, worth a combined $23.5M — up 6.6% from $22M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CO and 1 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 10 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.68M. The largest seller was Norges Bank, cutting an estimated $439K.
- 32 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2020, down from 33 in Q1 2020.
- Funds reported $23.5M of Global Cord Blood Corporation stock for Q2 2020, up 6.6% quarter-over-quarter.
- 1 fund opened new Global Cord Blood Corporation positions in Q2 2020 and 2 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation buyer in Q2 2020 was Renaissance Technologies, an estimated $1.68M added.
- The largest Global Cord Blood Corporation seller in Q2 2020 was Norges Bank, an estimated $439K sold.
Based on aggregated 13F filings for Q2 2020.